StockData
Opthea Ltd logo

Opthea Ltd (CKDXF) stock

CKDXFOTCBiological Products, (No Diagnostic Substances)Fiscal year ends June 30Also trades as CYVNY
Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Sep 15, 2025Score 0/30
$0.01+0.00 (0.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

Opthea price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Opthea's price to sales ratio was 61.2× on Oct 19, 2026, against 280.8× a year earlier. Over the last 3 years it ranged from 61.2× to 413.9×, with a median of 215.2×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 202661.2×−219.6
2025Aug 29, 2025280.8×+0.0
2024Dec 31, 2024280.8×+132.2
2023Dec 29, 2023148.6×−265.3
2020Aug 31, 2020413.9×–

More Opthea figures

See a number that looks wrong?